Edasalonexent Uses, Dosage, Side Effects and more
Edasalonexent is under investigation in clinical trial NCT01511900 (A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes).
| Attribute | Details |
|---|---|
| Trade Name | Edasalonexent |
| Generic | Edasalonexent |
| Edasalonexent Other Names | Edasalonexent |
| Type | |
| Formula | C31H42N2O3 |
| Weight | Average: 490.688 Monoisotopic: 490.31954322 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
